Jammu, Aug 10: In order to take care of the patients suffering from reactions during blood transfusion, Jammu AIIMS has collaborated with National Institute of Biologicals, Noida, to Advance ‘Hemovigilance Practices’.
“The Jammu AIIMS would be the first hospital in J&K to look after the different complications which a patient faces during blood transfusion,” Director AIIMS, Dr Shakti Gupta informed Rising Kashmir, while adding, “it would also be for the first time the complications and different kinds of reactions faced by a patient during blood transfusion would be directly reported to National Hemovigilance organization of India”.
In this regard, the Department of Transfusion Medicine at AIIMS Jammu, in collaboration with the National Institute of Biologicals (NIB) Noida, successfully conducted a two-day Continuing Medical Education (CME) program focused on advancing hemovigilance practices.
The event was held on 9th and 10th August 2024. This two-day CME on “Hemovigilance and its clinical relevance” was aimed at sensitizing the Faculty from Clinical Departments, Senior residents, Nursing faculty, Senior Nursing officers, and Nursing Officers of the Institute about the clinical relevance of the concept of Hemovigilance.
The CME was attended by 120 participants. This two-day event was inaugurated by the Chief Guest, Director AIIMS, Jammu, Prof. (Dr.) Shakti Kumar Gupta.
The 2-day program featured a series of expert-led sessions and interactive discussions on the latest advancements and best practices in hemovigilance, a critical component in ensuring the safety and efficacy of blood transfusions.
The program included various interactive talks and expert-led sessions on the most recent developments and best practices in hemovigilance, which is essential to ensure the safety and efficacy of blood transfusions.
